4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Procter & Gamble Health Limited (PGHL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 1,276 employees. Its market capitalization is roughly ₹91 billion. In the fiscal year ended 2026-03-31, PGHL reported ₹13.9B in revenue and ₹3.3B in net income.
Procter & Gamble Health Limited manufactures and markets pharmaceutical and chemical products in India and internationally. It offers over-the-counter products, vitamins, minerals, and supplements under the Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen brand names.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | ₹13.9B | ₹11.3B | ₹12.1B | ₹10.9B |
| Gross Profit | ₹9.9B | ₹7.7B | ₹8.1B | ₹7.2B |
| Operating Income (EBIT) | ₹4.3B | ₹2.8B | ₹3.0B | ₹2.5B |
| Net Income | ₹3.3B | ₹2.0B | ₹2.3B | ₹1.9B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹3.6B | ₹3.7B | ₹3.7B | ₹3.2B | ₹3.4B | — |
| Gross Profit | ₹2.7B | ₹2.8B | ₹2.6B | ₹2.6B | ₹2.4B | — |
| Operating Income (EBIT) | ₹936M | ₹1.3B | ₹1.0B | ₹1.1B | ₹849M | — |
| Net Income | ₹962M | ₹946M | ₹776M | ₹885M | ₹662M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Dividends Paid | (₹3.4B) | (₹4.1B) | (₹938M) | (₹2.8B) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2025-03-31 |
|---|---|
| Dividends Paid | (₹1.3B) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | ₹8.4B | ₹7.9B | ₹11.0B | ₹8.9B |
| Total Liabilities | ₹3.2B | ₹2.6B | ₹3.5B | ₹2.7B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PGHL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms